A Study to Evaluate the Efficacy of MEDI-528 on Late Asthmatic Response With Atopic Asthma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

January 31, 2008

Conditions

Asthma

Interventions

BIOLOGICAL

MEDI-528 9 mg/kg

MEDI-528 at a single dose of 9 mg/kg administered as an intravenous infusion

OTHER

Placebo

Placebo administered as a single intravenous infusion

Trial Locations (3)

McMaster University, Hamilton

Hopital Laval, Québec

University of Saskatchewan, Saskatoon